This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5W Public Relations Adds Absorption Pharmaceuticals To Its Consumer Brands Client Roster

NEW YORK, Dec. 7, 2012 /PRNewswire/ --  5WPR, one of the 25 largest independent Public Relations firms in the U.S., today announced the addition of Absorption Pharmaceuticals to its diverse roster of consumer product clients. Absorption Pharmaceuticals is the manufacturer of Promescent, the only FDA-approved topical use treatment for premature ejaculation (PE).   For Absorption Pharmaceuticals, 5W Public Relations will execute a multi-tiered media relations campaign.

"We are excited to be working with this innovative company," said Ronn Torossian, Founder of 5W Public Relations. "We look forward to helping this brand capture additional market share and elevating its visibility within leading media."

"As Absorption Pharmaceuticals continues to expand and offer an exceptional product to consumers, we are excited to let consumers know about our life-changing product," said Jeff Abraham, CEO of Absorption Pharmaceuticals.


5W Public Relations (5W) is a full-service agency known for cutting edge programs that engage people with businesses, issues and ideas.  With more than 90 professionals serving clients in B2C (Beauty & Fashion, Consumer Brands, Entertainment, Food & Beverage, Health & Wellness, Travel & Hospitality, Technology, Nonprofit), B2B (Corporate Communications, Reputation Management, CSR, Sustainability Communications), Public Affairs, Crisis Communications and digital strategy, 5W brings leading businesses a resourceful, bold and results driven approach to communications. Learn more at

SOURCE 5W Public Relations
Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,084.49 +33.74 0.20%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,830.47 +19.6820 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs